Provided by Tiger Trade Technology Pte. Ltd.

Protalix BioTherapeutics

2.48
+0.08003.33%
Post-market: 2.46-0.0160-0.65%18:50 EDT
Volume:1.02M
Turnover:2.47M
Market Cap:199.44M
PE:10.49
High:2.48
Open:2.39
Low:2.36
Close:2.40
52wk High:3.19
52wk Low:1.52
Shares:80.42M
Float Shares:76.54M
Volume Ratio:2.12
T/O Rate:1.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2364
EPS(LYR):-0.0841
ROE:31.23%
ROA:15.42%
PB:2.79
PE(LYR):-29.50

Loading ...

Mar 25, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Mar 23, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Mar 18, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Mar 12, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 12, 2020

Major Issues Report

Current report, items 1.01, 3.02, 8.01, and 9.01
Mar 09, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 06, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Dec 20, 2019

Major Issues Report

Current report, items 3.03, 5.03, and 9.01
Dec 19, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Dec 09, 2019

Major Issues Report

Current report, items 5.07, 8.01, and 9.01
Nov 18, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Nov 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 17, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Sep 24, 2019

Major Issues Report

Current report, items 8.01 and 9.01